40
https://pubmed.ncbi.nlm.nih.gov/38116433
A 6-methyl modification on certain antifolate drugs, like pemetrexed, abolishes transport by the ubiquitous RFC while preserving antitumor efficacy and selectivity for tumor-selective transporters, suggesting a promising approach for tumor-targeted therapeutics.